Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention
| Autor: | Gagnon, Eloi, Arsenault, Benoit J. |
|---|---|
| Zdroj: | In Atherosclerosis April 2024 391 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect